Skip to main content
. 2023 Sep 27;14:6041. doi: 10.1038/s41467-023-41678-9

Fig. 4. Difference in neutralizing antibodies against wild-type, BA.1, BA.5, BQ.1.1, and XBB.1.5 by total number of COVID-19 vaccine doses.

Fig. 4

There was no significant difference in neutralizing antibodies against any subvariant in those receiving 4 (n = 8) versus 5 doses (n = 90). Solid red line indicates median level. Dots represent individual serum samples collected (n = 98 for each timepoint).